Top Story

Iridex posts third quarter revenue increase

November 20, 2018

Alcon, Verily shelve glucose-monitoring lens project

November 19, 2018
Alcon and Verily have suspended work on a glucose-sensing smart contact lens for patients with diabetes, according to a post on Verily’s website. The companies…

Adverum reports increased third quarter loss

November 19, 2018
Adverum Biotechnologies reported an increase in its third quarter net loss to $21 million, or $0.34 per share, in 2018 compared with a net loss of $13.8 million, or…

Johnson & Johnson Vision, Singapore eye organizations partner on global myopia project

November 19, 2018
Johnson & Johnson Vision, the Singapore National Eye Centre and the Singapore Eye Research Institute have announced a partnership to research the causes, prevention…

Nightstar posts quarterly loss

November 19, 2018
Nightstar Therapeutics reported a net loss of $7.6 million, or $0.27 per share, for 2018’s third quarter compared with a net loss of $8.2 million, or $0.38 per…
More Headlines »
Experimental Science

Effects of Antiangiogenic Drugs on Expression Patterns of Epigenetic Pathway Genes

Ophthalmic Surgery, Lasers and Imaging Retina, October 2018, Volume 49 Issue 10
To investigate the effects of antiangiogenic drugs on the transcription profile of acetylation genes in immortalized…
More »

Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently…
More »
Resource Centers
American Academy of Ophthalmology Meeting

American Academy of Ophthalmology Meeting

Meeting News

VIDEO: Glaucoma space treatment options advancing

November 7, 2018
More »